search
Back to results

Open Radical Prostatectomy and Erector Spinae Plane Block

Primary Purpose

Prostate Cancer, Anesthesia, Local, Pain, Postoperative

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Single-injection ultrasound-guided bilateral erector spinae plane (ESP) block-Sham
Single-injection ultrasound-guided bilateral erector spinae plane block-Lidocaine/Bupivacaine
Pain follow-up and monitorization
Sponsored by
BURHAN DOST
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Prostate Cancer focused on measuring Pain, Postoperative, Ultrasound Guided Erector Spinae Plane Block, Prostatectomy

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: AmericanSociety of Anesthesiologists (ASA) I-III patients between the ages of 18 and 65 who are scheduled for elective open radical prostatectomy.

Exclusion criteria:

  • Patients who do not give informed consent or do not want to participate in the study
  • Ages <18 or>65
  • ASA IV patients
  • Obesity (>100 kg, BMI >35 kg/m2)
  • Contraindications of regional anesthesia (coagulopathy, thrombocytopenia, or infection at injection site)
  • Serious renal, cardiac, or hepatic disease
  • Hypersensitivity to local anesthetics or a history of allergy
  • History of opioid or steroid use longer than four weeks
  • Psychiatric disorders
  • Analgesic preoperative treatment within the preceding 48 hours
  • In order to establish better standard surgery, operations shorter than 60 minutes and longer than 180 minutes will also be excluded

Sites / Locations

  • Ondokuz Mayis University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Group LB

Group S

Arm Description

Ultrasound-guided bilateral erector spinae plane block (10 ml 1% lidocaine + 10 ml 0.5% bupivacaine) + intravenous morphine patient-controlled analgesia.

Ultrasound-guided bilateral erector spinae plane block. block (20 ml Normal Saline) + intravenous morphine patient-controlled analgesia.

Outcomes

Primary Outcome Measures

Narcotic consumption in the first 24 hours after surgery
Morphine consumption in the first 24 hours will be measured by IV PCA. Patients will be able to request opioids via a PCA device when their NRS score is above 3.

Secondary Outcome Measures

Postoperative pain: NRS score
Pain status at rest and while coughing will be assessed by NRS score at 1, 3, 6, 12, 18, and 24 hours after surgery. In addition, the time until first analgesic requirement will be recorded.The NRS is an 11-point numeric scale which ranges from 0 to 10.
Postoperative nausea and vomiting (PONV)
The patients will be verbally evaluated according to a descriptive five-point PONV scale. If a score of 3 or more is registered, ondansetron 4 mg IV will be administered and repeated after 8 hours if required.The PONV scale is 0 = no nausea; 1 = slight nausea; 2 = moderate nausea; 3 = vomiting once;and 4 = vomiting more than once
Intraoperative remifentanil consumption
Following anesthesia induction, a bispectral index (BIS) of 40 to 50 will be maintained with sevoflurane. When the BIS measures 40-50, the remifentanil infusion rate will be adjusted to consider ±20% blood pressure changes compared to baseline values.The total amount of remifentanil consumed will be recorded.

Full Information

First Posted
April 3, 2020
Last Updated
December 23, 2021
Sponsor
BURHAN DOST
Collaborators
Ondokuz Mayıs University
search

1. Study Identification

Unique Protocol Identification Number
NCT04337060
Brief Title
Open Radical Prostatectomy and Erector Spinae Plane Block
Official Title
Single-injection Ultrasound-guided Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Open Radical Prostatectomy: A Prospective Randomized Sham-controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
May 1, 2020 (Actual)
Primary Completion Date
January 11, 2021 (Actual)
Study Completion Date
January 11, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
BURHAN DOST
Collaborators
Ondokuz Mayıs University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the proposed study, a bilateral erector spinae plane (ESP) block [10 ml 1%lidocaine + 10 ml 0.5 % bupivacaine vs normal saline (NS)] will be performed preoperatively to patients undergoing open radical prostatectomy. Analgesic efficacy will be assessed on the numeric rating scale (NRS) along with intra- and 24 h post-operative narcotic consumption.
Detailed Description
It has been reported that the ESP block produces effective postoperative analgesia for abdominal surgeries by relieving both somatic and visceral pain. In the present study, the investigators presume that an ESP block will decrease narcotic consumption and NRS values both intraoperatively and during the first 24 postoperative hours. Patients will be divided into two groups: Group LB (Lidocaine-Bupivacaine): A bilateral ESP block will be performed preoperatively (10 ml 1%lidocaine + 10 ml 0.5% bupivacaine). In addition, IV morphine patient-controlled analgesia (PCA) will be applied postoperatively for 24 hours. Group S: A bilateral ESP block will be performed preoperatively (20 ml NS).In addition, IV morphine-PCA will be applied postoperatively for 24 hours.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer, Anesthesia, Local, Pain, Postoperative
Keywords
Pain, Postoperative, Ultrasound Guided Erector Spinae Plane Block, Prostatectomy

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group LB
Arm Type
Active Comparator
Arm Description
Ultrasound-guided bilateral erector spinae plane block (10 ml 1% lidocaine + 10 ml 0.5% bupivacaine) + intravenous morphine patient-controlled analgesia.
Arm Title
Group S
Arm Type
Sham Comparator
Arm Description
Ultrasound-guided bilateral erector spinae plane block. block (20 ml Normal Saline) + intravenous morphine patient-controlled analgesia.
Intervention Type
Procedure
Intervention Name(s)
Single-injection ultrasound-guided bilateral erector spinae plane (ESP) block-Sham
Other Intervention Name(s)
ESP block-Sham
Intervention Description
With the patient in the sitting position, 20 ml normal saline will be administered between the T11 spinous process and the erector spinae muscles with the guidance of an ultrasound probe placed on a parasagittal plane. Intraoperative analgesia: after anesthesia induction, paracetamol 1 gr intravenous (IV)+ tenoxicam 20 mg IV + morphine 0.05 mg/kg IV (max 4 mg). Postoperative analgesia: IV morphine patient-controlled analgesia (PCA) of 0.5 mg/ml morphine (demand dose 1 mg; lockout interval 8 m; 6 mg/h limit).
Intervention Type
Procedure
Intervention Name(s)
Single-injection ultrasound-guided bilateral erector spinae plane block-Lidocaine/Bupivacaine
Other Intervention Name(s)
ESP block-Lidocaine/Bupivacaine
Intervention Description
With the patient in the sitting position, 10 ml 1% lidocaine + 10 ml 0.5% bupivacaine will be administered between the T11 spinous process and the erector spinae muscles with the guidance of an ultrasound probe placed on a parasagittal plane. Intraoperative analgesia: After anesthesia induction, paracetamol 1 gr IV + tenoxicam 20 mg IV + morphine 0.05 mg/kg IV (max 4 mg). Postoperative analgesia: IV PCA of 0.5 mg/ml morphine (demand dose 1 mg; lockout interval 8 m; 6 mg/h limit).
Intervention Type
Other
Intervention Name(s)
Pain follow-up and monitorization
Other Intervention Name(s)
IV morphine-PCA
Intervention Description
Numeric Rating Scale (NRS) pain score will be recorded from 15th minute in recovery room followed by 1.-3.-6.-12.-18.-24.hours with two different conditions which are at rest and while couching.If NRS score becomes ≥4 Dexketoprofen 50 mg will be administered (max 4 times).
Primary Outcome Measure Information:
Title
Narcotic consumption in the first 24 hours after surgery
Description
Morphine consumption in the first 24 hours will be measured by IV PCA. Patients will be able to request opioids via a PCA device when their NRS score is above 3.
Time Frame
Postoperative day 1
Secondary Outcome Measure Information:
Title
Postoperative pain: NRS score
Description
Pain status at rest and while coughing will be assessed by NRS score at 1, 3, 6, 12, 18, and 24 hours after surgery. In addition, the time until first analgesic requirement will be recorded.The NRS is an 11-point numeric scale which ranges from 0 to 10.
Time Frame
Postoperative day 1
Title
Postoperative nausea and vomiting (PONV)
Description
The patients will be verbally evaluated according to a descriptive five-point PONV scale. If a score of 3 or more is registered, ondansetron 4 mg IV will be administered and repeated after 8 hours if required.The PONV scale is 0 = no nausea; 1 = slight nausea; 2 = moderate nausea; 3 = vomiting once;and 4 = vomiting more than once
Time Frame
Postoperative day 1
Title
Intraoperative remifentanil consumption
Description
Following anesthesia induction, a bispectral index (BIS) of 40 to 50 will be maintained with sevoflurane. When the BIS measures 40-50, the remifentanil infusion rate will be adjusted to consider ±20% blood pressure changes compared to baseline values.The total amount of remifentanil consumed will be recorded.
Time Frame
Postoperative day 1

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
Only Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: AmericanSociety of Anesthesiologists (ASA) I-III patients between the ages of 18 and 65 who are scheduled for elective open radical prostatectomy. Exclusion criteria: Patients who do not give informed consent or do not want to participate in the study Ages <18 or>65 ASA IV patients Obesity (>100 kg, BMI >35 kg/m2) Contraindications of regional anesthesia (coagulopathy, thrombocytopenia, or infection at injection site) Serious renal, cardiac, or hepatic disease Hypersensitivity to local anesthetics or a history of allergy History of opioid or steroid use longer than four weeks Psychiatric disorders Analgesic preoperative treatment within the preceding 48 hours In order to establish better standard surgery, operations shorter than 60 minutes and longer than 180 minutes will also be excluded
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
BURHAN DOST
Organizational Affiliation
Ondokuz Mayis University, School of Medicine, Department of Anesthesiology
Official's Role
Study Director
Facility Information:
Facility Name
Ondokuz Mayis University
City
Samsun
State/Province
Atakum
ZIP/Postal Code
55139
Country
Turkey

12. IPD Sharing Statement

Citations:
PubMed Identifier
31620856
Citation
Ibrahim M, Elnabtity AM. Analgesic efficacy of erector spinae plane block in percutaneous nephrolithotomy : A randomized controlled trial. Anaesthesist. 2019 Nov;68(11):755-761. doi: 10.1007/s00101-019-00673-w. Epub 2019 Oct 16.
Results Reference
background
PubMed Identifier
27501016
Citation
Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.
Results Reference
background
PubMed Identifier
28188621
Citation
Chin KJ, Adhikary S, Sarwani N, Forero M. The analgesic efficacy of pre-operative bilateral erector spinae plane (ESP) blocks in patients having ventral hernia repair. Anaesthesia. 2017 Apr;72(4):452-460. doi: 10.1111/anae.13814. Epub 2017 Feb 11.
Results Reference
background
PubMed Identifier
32076689
Citation
Diwan S, Nair A. Is Paravertebral-Epidural Spread the Underlying Mechanism of Action of Erector Spinae Plane Block? Turk J Anaesthesiol Reanim. 2020 Feb;48(1):86-87. doi: 10.5152/TJAR.2019.81226. Epub 2019 Nov 11. No abstract available.
Results Reference
background
PubMed Identifier
30886130
Citation
Kot P, Rodriguez P, Granell M, Cano B, Rovira L, Morales J, Broseta A, Andres J. The erector spinae plane block: a narrative review. Korean J Anesthesiol. 2019 Jun;72(3):209-220. doi: 10.4097/kja.d.19.00012. Epub 2019 Mar 19.
Results Reference
background
PubMed Identifier
31031480
Citation
Tulgar S, Kapakli MS, Kose HC, Senturk O, Selvi O, Serifsoy TE, Thomas DT, Ozer Z. Evaluation of Ultrasound-Guided Erector Spinae Plane Block and Oblique Subcostal Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy: Randomized, Controlled, Prospective Study. Anesth Essays Res. 2019 Jan-Mar;13(1):50-56. doi: 10.4103/aer.AER_194_18.
Results Reference
background
PubMed Identifier
30988534
Citation
Singh S, Kumar G, Akhileshwar. Ultrasound-guided erector spinae plane block for postoperative analgesia in modified radical mastectomy: A randomised control study. Indian J Anaesth. 2019 Mar;63(3):200-204. doi: 10.4103/ija.IJA_758_18.
Results Reference
background

Learn more about this trial

Open Radical Prostatectomy and Erector Spinae Plane Block

We'll reach out to this number within 24 hrs